# Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

> **NCT05001776** · PHASE4 · COMPLETED · sponsor: **National Medical Research Center for Therapy and Preventive Medicine** · enrollment: 105 (actual)

## Conditions studied

- Superficial Vein Thrombosis
- Endovenous Laser Ablation

## Interventions

- **PROCEDURE:** Endovenous laser ablation
- **DRUG:** Fondaparinux Sodium

## Key facts

- **NCT ID:** NCT05001776
- **Lead sponsor:** National Medical Research Center for Therapy and Preventive Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-16
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05001776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05001776, "Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05001776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*